AbbVie to Buy Shire for $54.8 Billion

July 18 (Bloomberg) -- AbbVie Inc. agreed to buy Shire Plc for about 32 billion pounds ($54.8 billion), becoming the latest U.S. health-care company to shift its tax residence abroad in a record surge in industry deals. Anna Edwards and Caroline Hyde report on Bloomberg Television's "The Pulse." (Source: Bloomberg)

Exchange Income CEO Fights Back Against Short Seller
14:40 - Exchange Income released its second-quarter results three weeks in advance in order to dispel some of the negative sentiment after short-seller Marc Cohodes targets the company. Double-digit earnings and revenue growth, however, weren’t enough to soothe investors. CEO Mike Pyle joins Bloomberg TV Canada's Lily Jamali to defend his company from short sellers' claims. (Source: Bloomberg)
  • Inflation Paves Way for More Canada Rate Hikes
  • Bloomberg Markets: The Trump Economy 7/21
  • Lyft Outlines Self-Driving Car Plans